Table 1.
Participants in bladder and kidney national cancer institute cooperative group trials and proportion of incidence cancer patients in the United States according to race/ethnicity, age, and sex, 2000 to 2019.
| Characteristic | Bladder and kidney cancer n = 14,094 | Percent incident cancer in U.S. | Bladder cancern = 5,468 | Percent incident cancer in U.S. | Kidney cancer n = 8,626 | Percent incident cancer in U.S. |
|---|---|---|---|---|---|---|
| Race/ethnicity | No (%) | % | No (%) | % | No (%) | % |
| Non-Hispanic White | 12,169 (86.3%) | 83.25% | 4,780 (87.4%) | 88.02% | 7,389 (85.7%) | 76.84% |
| Black | 662 (4.7%) | 7.69% | 232 (4.2%) | 5.15% | 420 (5.0%) | 11.0% |
| Hispanic | 660 (4.7%) | 6.06% | 197 (3.6%) | 4.03% | 463 (5.4%) | 8.79% |
| Asian/Pacific Islander | 312 (2.2%) | 1.75% | 143 (2.6%) | 1.56% | 169 (2.0%) | 1.99% |
| American Indian/Alaska Native | 61 (0.4%) | 0.51% | 15 (0.3%) | 0.29% | 46 (0.5%) | 0.81% |
| Other | 230 (1.6%) | 0.74% | 101 (1.8%) | 0.94% | 129 (1.5%) | 0.48% |
| Age, years | ||||||
| <65 | 7,902 (56.1%) | 36.52% | 2,196 (40.2%) | 27.06% | 5,706 (66.1%) | 49.24% |
| >65 | 6,192 (43.9%) | 63.47% | 3,272 (59.8%) | 72.93% | 2,920 (33.9%) | 50.75% |
| Sex | ||||||
| Female | 3,701 (26.3%) | 30.08% | 1,134 (20.7%) | 24.56% | 2,567 (29.8%) | 37.49% |
| Male | 10,393 (73.7%) | 69.91% | 4,334 (79.3%) | 75.43% | 6,059 (70.2%) | 62.5% |